Chugai signs licensing deal with Verastem for cancer drug

Japanses firm Chugai Pharmaceutical Co., Ltd. has announced that the Company entered into a global licensing agreem...

January 10, 2020 | Friday | News
Huya Bioscience ropes in Meiji as distributor for Asian region

US based HUYA Bioscience International CEO & Executive Chair, Dr. Mireille Gillings announced the appointm...

January 10, 2020 | Friday | News
Alma receives excellence award in Japan

Alma, a global innovator of Laser, Light-based, Radiofrequency, Plasma and Ultrasound solutions for the aesthetic and su...

January 9, 2020 | Thursday | News
Transgene, NEC initiate trials with AI-Powered Cancer Vaccine

French firm Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of canc...

January 7, 2020 | Tuesday | News
aTyr Pharma, Kyorin to work on interstitial lung diseases

US based aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of innovative medicines b...

January 7, 2020 | Tuesday | News
Urovant inks $300M loan agreement with Sumitomo Pharma

Urovant Sciences, a subsidiary of Sumitomo Dainippon Pharma has announced that it has entered into a $300 million term l...

January 2, 2020 | Thursday | News
Japan develops new tumour-on-a-chip device

Kyoto University researchers have developed a new 'tumor-on-a-chip' device that can better mimic the environment inside ...

January 1, 2020 | Wednesday | News
Eisai presented research data on Eribulin (Halaven) at 42nd Annual SABCS2019

Eisai Co., Ltd. presented its latest information on its in-house discovered and developed eribulin mesylate (halich...

December 16, 2019 | Monday | News
Daiichi Sankyo unveils drug for treating colorectal cancer

Daiichi Sankyo Company has announced that it has launched the antitumor agent bevacizumab BS for intravenous drip infusi...

December 31, 2019 | Tuesday | News
Pentax Medical Remains Committed to Endoscopic Ultrasound Business

PENTAX Medical continues its commitment to Endoscopic Ultrasound (EUS) as an indispensable part of its flexible endoscop...

December 19, 2019 | Thursday | News
Astellas strengthens immuno-oncology portfolio by acquiring Xyphos

Japan based Astellas Pharma Inc. and US headquartered Xyphos Biosciences, Inc. have announced that Astellas has acq...

December 27, 2019 | Friday | News
USFDA approves Daiichi Sankyo and AstraZeneca’s breast cancer drug

Daiichi Sankyo and AstraZeneca have announced that the U.S. Food and Drug Administration (FDA) has approved ENHERTU®...

December 26, 2019 | Thursday | News
Gilead, Eisai to co-promote drug in Japan for RA treatment

Gilead Sciences, Inc. and Eisai Co., Ltd. have announced that Gilead Sciences K.K. and Eisai have entered into an agreem...

December 26, 2019 | Thursday | News
Eisai gets USFDA nod for insomnia drug

Eisai has announced that the U.S. Food and Drug Administration (FDA) approved DAYVIGO™ (lemborexant) 5 mg and...

December 24, 2019 | Tuesday | News
Towa to acquire Esteve’s generic division for 320M euros

Japan based TOWA PHARMACEUTICAL CO., LTD. and Spain based pharma company ESTEVE have announced that TOWA will acquire 10...

December 24, 2019 | Tuesday | News
Takeda, Turnstone Biologics to develop novel viral immunotherapies

US based Turnstone Biologics, a biotechnology company pioneering the development of engineered viral immunotherapies,&nb...

December 20, 2019 | Friday | News
FDA grants accelerated approval to Astellas' and Seattle Genetics' PADCEV

Astellas Pharma Inc.  and Seattle Genetics, Inc. have announced that the U.S. Food and Drug Administration (FD...

December 19, 2019 | Thursday | News
PHC Corporation makes investment in Kakehashi

Japan based PHC Corporation has announced it was taking a stake in KAKEHASHI Inc., based on a share purchase agreement w...

December 19, 2019 | Thursday | News